Allurion Technologies (ALURD) Change in Account Payables (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Change in Account Payables came in at -$347000.0 in Q1 2026, up 85.6% YoY from -$186965.6 in Q1 2025, and down 151.56% on a QoQ basis from $673000.0 in Q4 2025.
Allurion Technologies (ALURD) Change in Account Payables (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Change in Account Payables data on file, last reported at -$347000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 85.6% year-over-year to -$347000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 86.31% YoY) and the FY2025 annual result came in at -$3.1 million, up 19.95% from the prior year.
- Change in Account Payables retreated to -$347000.0 in Q1 2026, from $673000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $5.4 million in Q1 2023 to a low of -$4.1 million in Q2 2024.
- A 5-year average of -$103133.3 and a median of -$333000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 335.69% — and 2024, when it sank 1117.72%.
- Tracing ALURD's Change in Account Payables over 5 years: stood at $269000.0 in 2022, then soared by 335.69% to $1.2 million in 2023, then tumbled by 385.49% to -$3.3 million in 2024, then soared by 120.11% to $673000.0 in 2025, then sank by 151.56% to -$347000.0 in 2026.
- The last three Change in Account Payables figures came in at -$347000.0 (Q1 2026), $673000.0 (Q4 2025), and -$921000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -347,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -347,000.00 |
| Mar 31, 2026 | -347,000.00 |
| Dec 31, 2025 | 673,000.00 |
| Dec 31, 2025 | 673,000.00 |
| Sep 30, 2025 | -921,000.00 |
| Sep 30, 2025 | -921,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Jun 30, 2025 | -484,000.00 |
| Mar 31, 2025 | -2.41 Mn |
| Mar 31, 2025 | -2.41 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -4.06 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |